Development of a Measure of Social Connectedness for Survivors of Pediatric Brain Tumors
Development of a Measure of Social Connectedness for Survivors of Pediatric Brain Tumors
Dr. Matthew Hocking, Ph.D. – The Children's Hospital of Philadelphia, Philadelphia, PA
Tumor-specific PROTAC development as a new therapeutic approach for osteosarcoma
Tumor-specific PROTAC development as a new therapeutic approach for osteosarcoma
Dr. Gunda Georg, Ph.D. – Regents of the University of Minnesota - Twin Cities, Minneapolis, MN
Linking the Gut Microbiome to Chemotherapy Toxicity in Pediatric ALL
Linking the Gut Microbiome to Chemotherapy Toxicity in Pediatric ALL
Dr. Eran Elinav, M.D., Ph.D. – Weizmann Institute of Science, Israel
Pulmonary complications in children with solid tumors
Pulmonary complications in children with solid tumors
Dr. S.M.P.J. Prevaes; Dr. M. van Grotel – Princess Máxima Center, Utrecht, The Netherlands
Targeting apoptosis to prevent cancer therapy-induced cardiovascular dysfunction in pediatric patients
Targeting apoptosis to prevent cancer therapy-induced cardiovascular dysfunction in pediatric patients
Dr. Kristopher Sarosiek, Ph.D. – President and Fellows of Harvard College, Harvard T. H. Chan School of Public Health, Boston, MA